TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Operating Liabilities
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Operating Liabilities of -$1.60 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLiabilities · last filed 2015-11-06
- TRAVERE THERAPEUTICS, INC. increase (decrease) in operating liabilities for the quarter ending 2014-09-30 was -$1.60M.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in operating liabilities for the quarter ending 2014-06-30 was $3.30M.
| Period end | Increase (Decrease) in Operating Liabilities 3 month | Increase (Decrease) in Operating Liabilities 6 month | Increase (Decrease) in Operating Liabilities 9 month |
|---|---|---|---|
| 2014-09-30 | -$1.60M 10-Q · filed 2015-11-06 | $1.70M derived: sum of 2 quarters · filed 2015-11-06 | $200.00K 10-Q · filed 2015-11-06 |
| 2014-06-30 | $3.30M 10-Q · filed 2015-08-10 | $1.80M 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |